Article

Michael J. Mauro Discusses the Diagnosis of CML

Author(s):

Michael J. Mauro

Michael J. Mauro, leader, Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses the diagnosis of chronic myeloid leukemia (CML).

Michael J. Mauro, leader, Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses the diagnosis of chronic myeloid leukemia (CML).

Related Videos
Image of a woman with tied back hair, wearing pearl earrings.
Image of a woman with layered hair, wearing a bright blue cardigan.
Image of a man with short black hair.
Image of man with gray hair.
Image of woman with black hair.
Image of a man wearing a black suit and tie.
Image of a man with white hair and a white goatee.
Image of a woman with brown wavy hair, wearing a navy blue top.
Image of a man wearing a suit with a red bowtie.
Related Content
Illustration of blood cells.
October 9th 2024

Brukinsa Recommended Versus Imbruvica in R/R CLL, SLL

Ashley Chan
Patients with relapsed or refractory CLL or SLL may benefit from receiving Brukinsa instead of Imbruvica, as Brukinsa demonstrated superior effectiveness.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Illustration of a man with round glasses and a goatee.
October 7th 2024

My Bitter Chemotherapy Pills for Chronic Lymphocytic Leukemia

Chester Freeman
I’ve recently started on chemotherapy pills instead of infusions and the bitterness reminds me to accept not only the bitterness of the pill, but in life too.
Top Headlines on CAR-T Cell Therapy
December 4th 2023

Top Headlines on CAR-T Cell Therapy

Alex Biese Brielle Benyon
From FDA concerns to a potential new drug, CAR-T cell therapies were dominating oncology headlines last week.
Photo courtesy of Mike Peters.
October 4th 2024

Mike Peters of the Alarm in Remission, Broadway Star Gavin Creel Dies and More

Alex Biese Ashley Chan
From good news for a rock star to the deaths of stage and screen stars, here’s what’s happening in the cancer space this week.
Illustration of cells.
September 23rd 2024

Outpatient CAR-T Cell Therapy May Be Safe in Hematologic Malignancies

Spencer Feldman
CAR-T cell therapies administered in an outpatient setting may be safe and feasible without intensive remote monitoring in hematologic malignancies.